Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients

Marco Montillo; Alessandra Tedeschi; Gianluca Gaidano; Marta Coscia; Valeria Belsito Petrizzi; Ester Orlandi; Nicola Cascavilla; Paolo Ghia; Marina Motta; Andrea Gallamini; Anna Maria Frustaci; Davide Rossi; Lorenzo De Paoli; Michele Nichelatti; Enrica Morra; Massimo Massaia

doi:10.3324/haematol.2014.106740

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients

Marco Montillo
, Alessandra Tedeschi
, Gianluca Gaidano
, Marta Coscia
, Valeria Belsito Petrizzi
, Ester Orlandi
, Nicola Cascavilla
, Paolo Ghia
, Marina Motta
, Andrea Gallamini
, Anna Maria Frustaci
, Davide Rossi
, Lorenzo De Paoli
, Michele Nichelatti
, Enrica Morra
, Massimo Massaia

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Lettera › peer review

Lingua originale	Inglese
pagine (da-a)	e159-e161
Rivista	Haematologica
Volume	99
Numero di pubblicazione	9
DOI	https://doi.org/10.3324/haematol.2014.106740
Stato di pubblicazione	Pubblicato - 1 set 2014

Accesso al documento

10.3324/haematol.2014.106740

Altri file e collegamenti

Link to publication in Scopus

Cita questo

Montillo, M., Tedeschi, A., Gaidano, G., Coscia, M., Petrizzi, V. B., Orlandi, E., Cascavilla, N., Ghia, P., Motta, M., Gallamini, A., Frustaci, A. M., Rossi, D., De Paoli, L., Nichelatti, M., Morra, E., & Massaia, M. (2014). Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. Haematologica, 99(9), e159-e161. https://doi.org/10.3324/haematol.2014.106740

@article{6ba3bf3521464a0d9e6354da74f04be0,

title = "Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients",

keywords = "Bendamustine, Effective treatment, Relapsed/refractory chronic lymphocytic leukemia",

author = "Marco Montillo and Alessandra Tedeschi and Gianluca Gaidano and Marta Coscia and Petrizzi, \{Valeria Belsito\} and Ester Orlandi and Nicola Cascavilla and Paolo Ghia and Marina Motta and Andrea Gallamini and Frustaci, \{Anna Maria\} and Davide Rossi and \{De Paoli\}, Lorenzo and Michele Nichelatti and Enrica Morra and Massimo Massaia",

year = "2014",

month = sep,

day = "1",

doi = "10.3324/haematol.2014.106740",

language = "English",

volume = "99",

pages = "e159--e161",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "9",

}

Montillo, M, Tedeschi, A, Gaidano, G, Coscia, M, Petrizzi, VB, Orlandi, E, Cascavilla, N, Ghia, P, Motta, M, Gallamini, A, Frustaci, AM, Rossi, D, De Paoli, L, Nichelatti, M, Morra, E & Massaia, M 2014, 'Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients', Haematologica, vol. 99, n. 9, pagg. e159-e161. https://doi.org/10.3324/haematol.2014.106740

TY - JOUR

T1 - Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients

AU - Montillo, Marco

AU - Tedeschi, Alessandra

AU - Gaidano, Gianluca

AU - Coscia, Marta

AU - Petrizzi, Valeria Belsito

AU - Orlandi, Ester

AU - Cascavilla, Nicola

AU - Ghia, Paolo

AU - Motta, Marina

AU - Gallamini, Andrea

AU - Frustaci, Anna Maria

AU - Rossi, Davide

AU - De Paoli, Lorenzo

AU - Nichelatti, Michele

AU - Morra, Enrica

AU - Massaia, Massimo

PY - 2014/9/1

Y1 - 2014/9/1

KW - Bendamustine

KW - Effective treatment

KW - Relapsed/refractory chronic lymphocytic leukemia

UR - https://www.scopus.com/pages/publications/84907374559

U2 - 10.3324/haematol.2014.106740

DO - 10.3324/haematol.2014.106740

M3 - Letter

SN - 0390-6078

VL - 99

SP - e159-e161

JO - Haematologica

JF - Haematologica

IS - 9

ER -